While the medication itself does not have specific dosing adaptations for mild to moderate kidney or liver issues, certain side effects can increase risk
Week 48: Phase 2 Results Kept Building At 48 weeks in the same Phase 2 trial, the least-squares mean body-weight change was 17.1% in the combined 4 mg group, 22.8% in the combined 8 mg group, and 24.2% in the 12 mg group, compared with 2.1% for placebo
These compounds work by mimicking hormones produced in the gut after eating
The tracker works whether you stay on semaglutide, move to tirzepatide, or change again later your weight trend, meals, symptoms, and shot history stay on one timeline through every switch
It is a lot in absolute terms, but it is not experimental or dangerous
Some comparative points: Access and Convenience : Mail-order pharmacies deliver directly to patients, which is especially helpful for homebound or rural patients